Clinical trial

Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases

NCT07085676

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-09-01

PhasePHASE1

Study timeline

Study start (actual)2024-09-01Date precision: day

Registry last updated2026-05-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Systemic Sclerosis (SSc)unresolved

Idiopathic Inflammatory Myopathy (IIM)unresolved

Rheumatoid Arthritis (RA)unresolved

Systemic Lupus Erythematosus (SLE)unresolved

Multiple Sclerosis (MS) Primary Progressiveunresolved

Multiple Sclerosis (MS) Secondary Progressiveunresolved

Neuromyelitis Optica Spectrum Disorder (NMOSD)unresolved

Myasthenia Gravis (MG)unresolved

Antiphospholipid Antibody Syndromeunresolved

Interventions

HBI0101 CARTBIOLOGICAL

Sponsors & collaborators

Polina Stepenskylead sponsor

Mapped research locations

JerusalemIsrael1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07085676 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.